查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889208

全球器官保存市場：預測至2032年－按保存方法、器官類型、溶液類型、設備類型、分銷管道、最終用戶和地區進行分析

Organ Preservation Market Forecasts to 2032 - Global Analysis By Preservation Method, Organ Type, Solution Type, Equipment Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球器官保存市場價值將達到 2.9811 億美元，到 2032 年將達到 5.52 億美元，預測期內複合年成長率為 9.2%。

器官保存是指在移植前，將捐贈的器官在體外保持功能和健康狀態。它採用精確的冷卻方法、保存液和創新技術，以減少細胞損傷並延緩代謝衰退。這些技術能夠長期維持包括腎臟、肝臟、心臟和肺部在內的重要器官的功能，從而提高移植成功率和患者存活率。

根據美國人口普查局預測，到 2024 年，美國人口的 20% 將達到或超過 65 歲，這將導致與老齡化相關的疾病發生率增加，需要進行器官移植。

慢性病發生率呈上升趨勢

在全球範圍內，心臟病、肝損傷和糖尿病等慢性疾病的流行趨勢正在推動對器官保存技術的需求。隨著越來越多的患者發展到器官衰竭的嚴重階段，器官移植的需求顯著增加。這使得人們更加關注如何維持捐贈器官的長期活性。醫學篩檢的進步使得器官功能衰退的早期檢測成為可能，從而鼓勵更多患者接受移植治療。同時，文明病的增加也給醫療保健系統帶來了更大的壓力。因此，慢性疾病的快速成長是推動器官保存市場發展的強勁動力。

可用捐贈器官嚴重短缺

儘管器官移植的需求持續成長，但器官捐贈率仍相對較低。許多器官因在摘取時不符合存活標準而被丟棄。這種限制減少了移植成功的案例，並減緩了技術應用的進步。許多國家仍面臨嚴重的捐贈者短缺問題，可移植器官供不應求繼續阻礙整個市場的發展。

長期保存技術的發展

器官長期保存方法的出現帶來了巨大的市場前景。諸如機械灌注和先進的冷凍保存技術等，正在重新定義器官保存標準。這些解決方案可以擴大適用於移植的器官供應量。私人公司和研究機構都在優先推進該領域的突破。延長保存期限有助於改善移植網路中的運輸和協調。因此，長期保存技術將成為未來發展的主要驅動力。

來自替代療法的競爭

替代療法透過減少對保存的捐贈器官的需求，正日益影響市場。包括組織工程在內的再生醫學解決方案正在提供新的治療途徑。人工器官的研發也在快速推進。這些創新最終可能會降低多種疾病領域對器官移植的需求。患者和臨床醫生正擴大探索創傷較小的治療方案。因此，替代技術的廣泛應用可能會限制未來的市場成長。

新冠疫情的感染疾病：

疫情對器官移植手術和捐贈者物流造成了嚴重干擾。許多醫療機構取消了手術，優先救治重症患者。這些干擾也阻礙了保存材料的採購。同時，疫情凸顯了可靠保存方法的重要性。因此，先進且靈活的保存工具的研發速度加快。隨著醫療系統的逐步穩定，市場正重獲成長動力。

在預測期內，靜態冷凍保存（SCS）細分市場將佔據最大的市場佔有率。

由於其成熟的技術應用和廣泛的普及，靜態冷凍保存（SCS）預計將在預測期內佔據最大的市場佔有率。它仍然是全球保存重要器官的主要方法。其經濟性和易用性使其成為許多醫療機構的實用選擇。其簡便的操作也便於醫護人員持續使用。新型保存液配方的不斷湧現進一步提升了其性能。

在預測期內，研究和學術機構領域將實現最高的複合年成長率。

在預測期內，研究和學術機構領域預計將實現最高成長率，這主要得益於對技術進步的關注。對實驗室保存創新技術的持續投入正在推動這一領域的擴張。這些機構處於評估和改進新型保存工具的前沿，它們的努力為產業商業性突破奠定了堅實的基礎。與產業領導者的合作進一步增強了開發平臺。

佔比最大的地區：

由於北美擁有完善的醫療保健體系，預計在預測期內，北美將佔據最大的市場佔有率。該地區每年進行大量的器官移植手術，公共和私人機構都在積極推廣器官捐贈。器官保存技術的研究和開發尤其活躍，而完善的保險政策也為先進技術的普及提供了便利。

年複合成長率最高的地區：

由於醫療保健能力的不斷提升，預計亞太地區在預測期內將呈現最高的複合年成長率。民眾對器官捐贈的教育不斷加強，提高了器官移植的準備。多個國家正在加大對現代化設備和保存工具的投資。該地區器官相關疾病病例的增加推動了市場需求。政府的支持性政策正在加速科技的應用。因此，亞太地區預計將實現最高的成長率。

免費客製化服務：

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
  • 分析材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球器官保存市場（依保存方法分類）

  • 靜態冷藏（SCS）
  • 冷凍保存和玻璃化
  • 低溫機械灌注（HMP）
  • 亞常溫灌注
  • 常溫機械灌注（NMP）

6. 全球器官保存市場（依器官類型分類）

  • 腎
  • 角膜
  • 肝
  • 胰臟
  • 心
  • 肺
  • 其他組織

7. 全球器官保存市場（依解決方案類型分類）

  • 威斯康辛大學 (UW) 解決方案
  • Perfedex 和其他肺部保存液
  • CustodioIol HTK
  • Celsiol溶液
  • 器官特異性保存液

8. 全球器官保存市場（依設備類型分類）

  • 器官運輸裝置
  • 灌注裝置
  • 冷藏儲物容器
  • 攜帶式器官治療系統

9. 全球器官保存市場（依分銷管道分類）

  • 直接競標
  • 零售/批發
  • 線上

第10章 全球器官保存市場（依最終用戶分類）

  • 醫院及移植中心
  • 器官和組織庫
  • 研究和學術機構
  • 生物技術和製藥公司
  • 其他最終用戶

第11章 全球器官保存市場（依地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • TransMedics
  • XVIVO Perfusion AB
  • OrganOx Ltd
  • Getinge AB
  • Organ Recovery Systems
  • CryoLife, Inc.
  • BioLife Solutions, Inc.
  • Cryoport Systems, Inc.
  • Terumo Corporation
  • Dr. Franz Kohler Chemie GmbH
  • 21st Century Medicine
  • Vascular Perfusion Solutions, Inc.
  • Waters Medical Systems
  • Lifeline Scientific, Inc.
  • Preservation Solutions, Inc.
Product Code: SMRC32668

According to Stratistics MRC, the Global Organ Preservation Market is accounted for $298.11 million in 2025 and is expected to reach $552.00 million by 2032 growing at a CAGR of 9.2% during the forecast period. Organ preservation is the practice of keeping donated organs functional and healthy outside the body before they are transplanted. It uses precise cooling methods, preservation fluids, and innovative technologies to reduce cellular damage and delay metabolic decline. These techniques help critical organs including kidneys, livers, hearts, and lungs remain in good condition for longer periods, increasing their success in transplantation procedures and enhancing survival rates for patients in need.

According to the U.S. Census Bureau, it is projected that 20% of the U.S. population will be aged 65 and older by 2024, leading to a higher incidence of age-related diseases necessitating organ transplants.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

Chronic illnesses including heart disease, liver damage, and diabetes are becoming more common globally, fueling demand for organ preservation technologies. With more individuals reaching critical stages of organ failure, transplantation needs are increasing significantly. This has intensified the focus on maintaining donor organ viability for longer durations. Enhanced medical screening is enabling earlier detection of organ decline, pushing more patients toward transplant pathways. Rising lifestyle-related conditions are simultaneously adding pressure on healthcare systems. Consequently, the surge in chronic diseases is strongly propelling the organ preservation market.

Restraint:

Critical shortage of viable donor organs

While transplant requirements continue to escalate, organ donation remains comparatively low. A large number of organs are discarded because they fail to meet viability standards upon retrieval. This limitation reduces the number of successful transplant surgeries and slows technology uptake. Many countries still experience substantial gaps in donor contributions. Thus, the limited availability of transplant-ready organs continues to hinder overall market progress.

Opportunity:

Development of long-term preservation methods

The emergence of methods capable of maintaining organs for extended durations is opening strong prospects for the market. Technologies such as machine perfusion and advanced cryogenic storage are redefining preservation standards. These solutions can enlarge the pool of organs deemed suitable for transplantation. Both private companies and research institutions are prioritizing breakthroughs in this field. Enhanced preservation times support better transportation and coordination across transplant networks. As a result, long-term preservation technologies represent a key driver of future expansion.

Threat:

Competition from alternative treatments

Alternative therapies are increasingly influencing the market by reducing the need for preserved donor organs. Regenerative medicine solutions, including tissue engineering, are providing new pathways for treatment. Artificial organ development is continuing to advance at a rapid pace. Such innovations may eventually decrease transplant requirements in several disease areas. Patients and clinicians are gradually exploring less invasive treatment choices. Thus, the availability of substitutional technologies may limit future market growth.

Covid-19 Impact:

The pandemic caused major interruptions in transplant operations and donor logistics. Numerous centers halted surgeries to prioritize critical COVID-19 cases. These disruptions also created gaps in the procurement of preservation supplies. At the same time, the situation emphasized the importance of reliable preservation practices. This resulted in accelerated development of advanced, flexible preservation tools. As healthcare systems stabilize, the market is experiencing renewed momentum.

The static cold storage (SCS) segment is expected to be the largest during the forecast period

The static cold storage (SCS) segment is expected to account for the largest market share during the forecast period, due to its proven success and widespread usage. It continues to serve as the primary method for preserving major organs globally. Affordability and accessibility make it a practical choice for numerous healthcare settings. Its straightforward application supports consistent use among medical practitioners. New formulations of preservation fluids are strengthening its performance.

The research & academic institutes segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the research & academic institutes segment is predicted to witness the highest growth rate, due to their focus on technological advancement. Rising investments in laboratory-based preservation innovations are supporting expansion. These organizations are at the forefront of evaluating and refining new preservation tools. Their work strengthens the foundation for commercial breakthroughs in the sector. Partnerships with industry leaders further enhance development pipelines.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to its well-established medical systems. The region performs a large number of organ transplants each year. Public and private initiatives are actively promoting organ donation. Research and development activities related to preservation technologies are particularly strong. Supportive coverage policies make advanced technologies more accessible.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to expanding medical capabilities. Greater public education on organ donation is enhancing transplant readiness. Investments in modern equipment and preservation tools are increasing across several nations. The region faces rising cases of organ-related diseases, which drive market needs. Supportive government policies are helping accelerate technology adoption. Hence, Asia Pacific is set to achieve the highest growth rate.

Key players in the market

Some of the key players in Organ Preservation Market include TransMed, XVIVO Perf, OrganOx Lim, Getinge A, Organ Rec, CryoLife I, BioLife So, Cryoport S, Terumo Co, Dr. Franz K, 21st Centu, Vascular P, Waters Me, Lifeline S, and Preservat.

Key Developments:

In October 2025, OrganOx Ltd. announced the completion of its acquisition by Terumo Corporation, following satisfaction of all customary regulatory and closing conditions. OrganOx is now a wholly owned subsidiary of Terumo, positioning the company to unlock new opportunities to evolve its technology and reach more patients worldwide.

In September 2024, XVIVO Perfusion AB has entered into an agreement to acquire the transplant clinical workflow automation business, which includes, among other things, the development and distribution of the FlowHawkTM software platform, from Healthtech Solutions Inc. dba OmniLife. Organ transplantation is a complex, life-dependent process where flawless communication, both internal and external, is critical for transplant centers and the transplant ecosystem.

Preservation Methods Covered:

  • Static Cold Storage (SCS)
  • Cryopreservation & Vitrification
  • Hypothermic Machine Perfusion (HMP)
  • Subnormothermic Perfusion
  • Normothermic Machine Perfusion (NMP)

Organ Types Covered:

  • Kidney
  • Cornea
  • Liver
  • Pancreas
  • Heart
  • Lung
  • Other Tissues

Solution Types Covered:

  • University of Wisconsin (UW) Solution
  • Perfadex & Other Lungs Solutions
  • Custodiol HTK
  • Celsior Solution
  • Organ-Specific Specialized Solutions

Equipment Types Covered:

  • Organ Transport Devices
  • Perfusion Machines
  • Cold Storage Containers
  • Portable Organ Care Systems

Distribution Channels Covered:

  • Direct Tender
  • Retail/Wholesale
  • Online

End Users Covered:

  • Hospitals & Transplant Centers
  • Organ Banks & Tissue Banks
  • Research & Academic Institutes
  • Biotech & Pharma Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Organ Preservation Market, By Preservation Method

  • 5.1 Introduction
  • 5.2 Static Cold Storage (SCS)
  • 5.3 Cryopreservation & Vitrification
  • 5.4 Hypothermic Machine Perfusion (HMP)
  • 5.5 Subnormothermic Perfusion
  • 5.6 Normothermic Machine Perfusion (NMP)

6 Global Organ Preservation Market, By Organ Type

  • 6.1 Introduction
  • 6.2 Kidney
  • 6.3 Cornea
  • 6.4 Liver
  • 6.5 Pancreas
  • 6.6 Heart
  • 6.7 Lung
  • 6.8 Other Tissues

7 Global Organ Preservation Market, By Solution Type

  • 7.1 Introduction
  • 7.2 University of Wisconsin (UW) Solution
  • 7.3 Perfadex & Other Lungs Solutions
  • 7.4 Custodiol HTK
  • 7.5 Celsior Solution
  • 7.6 Organ-Specific Specialized Solutions

8 Global Organ Preservation Market, By Equipment Type

  • 8.1 Introduction
  • 8.2 Organ Transport Devices
  • 8.3 Perfusion Machines
  • 8.4 Cold Storage Containers
  • 8.5 Portable Organ Care Systems

9 Global Organ Preservation Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Direct Tender
  • 9.3 Retail/Wholesale
  • 9.4 Online

10 Global Organ Preservation Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Transplant Centers
  • 10.3 Organ Banks & Tissue Banks
  • 10.4 Research & Academic Institutes
  • 10.5 Biotech & Pharma Companies
  • 10.6 Other End Users

11 Global Organ Preservation Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 TransMedics
  • 13.2 XVIVO Perfusion AB
  • 13.3 OrganOx Ltd
  • 13.4 Getinge AB
  • 13.5 Organ Recovery Systems
  • 13.6 CryoLife, Inc.
  • 13.7 BioLife Solutions, Inc.
  • 13.8 Cryoport Systems, Inc.
  • 13.9 Terumo Corporation
  • 13.10 Dr. Franz Kohler Chemie GmbH
  • 13.11 21st Century Medicine
  • 13.12 Vascular Perfusion Solutions, Inc.
  • 13.13 Waters Medical Systems
  • 13.14 Lifeline Scientific, Inc.
  • 13.15 Preservation Solutions, Inc.

List of Tables

  • Table 1 Global Organ Preservation Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Organ Preservation Market Outlook, By Preservation Method (2024-2032) ($MN)
  • Table 3 Global Organ Preservation Market Outlook, By Static Cold Storage (SCS) (2024-2032) ($MN)
  • Table 4 Global Organ Preservation Market Outlook, By Cryopreservation & Vitrification (2024-2032) ($MN)
  • Table 5 Global Organ Preservation Market Outlook, By Hypothermic Machine Perfusion (HMP) (2024-2032) ($MN)
  • Table 6 Global Organ Preservation Market Outlook, By Subnormothermic Perfusion (2024-2032) ($MN)
  • Table 7 Global Organ Preservation Market Outlook, By Normothermic Machine Perfusion (NMP) (2024-2032) ($MN)
  • Table 8 Global Organ Preservation Market Outlook, By Organ Type (2024-2032) ($MN)
  • Table 9 Global Organ Preservation Market Outlook, By Kidney (2024-2032) ($MN)
  • Table 10 Global Organ Preservation Market Outlook, By Cornea (2024-2032) ($MN)
  • Table 11 Global Organ Preservation Market Outlook, By Liver (2024-2032) ($MN)
  • Table 12 Global Organ Preservation Market Outlook, By Pancreas (2024-2032) ($MN)
  • Table 13 Global Organ Preservation Market Outlook, By Heart (2024-2032) ($MN)
  • Table 14 Global Organ Preservation Market Outlook, By Lung (2024-2032) ($MN)
  • Table 15 Global Organ Preservation Market Outlook, By Other Tissues (2024-2032) ($MN)
  • Table 16 Global Organ Preservation Market Outlook, By Solution Type (2024-2032) ($MN)
  • Table 17 Global Organ Preservation Market Outlook, By University of Wisconsin (UW) Solution (2024-2032) ($MN)
  • Table 18 Global Organ Preservation Market Outlook, By Perfadex & Other Lungs Solutions (2024-2032) ($MN)
  • Table 19 Global Organ Preservation Market Outlook, By Custodiol HTK (2024-2032) ($MN)
  • Table 20 Global Organ Preservation Market Outlook, By Celsior Solution (2024-2032) ($MN)
  • Table 21 Global Organ Preservation Market Outlook, By Organ-Specific Specialized Solutions (2024-2032) ($MN)
  • Table 22 Global Organ Preservation Market Outlook, By Equipment Type (2024-2032) ($MN)
  • Table 23 Global Organ Preservation Market Outlook, By Organ Transport Devices (2024-2032) ($MN)
  • Table 24 Global Organ Preservation Market Outlook, By Perfusion Machines (2024-2032) ($MN)
  • Table 25 Global Organ Preservation Market Outlook, By Cold Storage Containers (2024-2032) ($MN)
  • Table 26 Global Organ Preservation Market Outlook, By Portable Organ Care Systems (2024-2032) ($MN)
  • Table 27 Global Organ Preservation Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 28 Global Organ Preservation Market Outlook, By Direct Tender (2024-2032) ($MN)
  • Table 29 Global Organ Preservation Market Outlook, By Retail/Wholesale (2024-2032) ($MN)
  • Table 30 Global Organ Preservation Market Outlook, By Online (2024-2032) ($MN)
  • Table 31 Global Organ Preservation Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Organ Preservation Market Outlook, By Hospitals & Transplant Centers (2024-2032) ($MN)
  • Table 33 Global Organ Preservation Market Outlook, By Organ Banks & Tissue Banks (2024-2032) ($MN)
  • Table 34 Global Organ Preservation Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 35 Global Organ Preservation Market Outlook, By Biotech & Pharma Companies (2024-2032) ($MN)
  • Table 36 Global Organ Preservation Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.